1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Kang, R.S. Daniels, C.M. Salerno, W.J. Radhakrishnan, I. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Cell(Cambridge,Mass.) CELLB5 0998 0092-8674 113 621 630 10.1016/S0092-8674(03)00362-3 12787503 Solution Structure of a CUE-Ubiquitin Complex Reveals a Conserved Mode of Ubiquitin Binding 2003 10.2210/pdb1otr/pdb pdb_00001otr 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5573.291 protein Cue2 Amino-terminal CUE Domain, Residues 6-54 1 man polymer 8568.769 Ubiquitin 1 man polymer HYPOTHETICAL 50.9 KD PROTEIN IN BUD2-MIF2 INTERGENIC REGION; hypothetical protein YKL090w no no NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS A polypeptide(L) no no MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n baker's yeast Saccharomyces Escherichia Escherichia coli sample CUE2 4932 Saccharomyces cerevisiae 469008 Escherichia coli BL21(DE3) BL21(DE3) PLASMID pMCSG baker's yeast Saccharomyces Escherichia Escherichia coli sample UBI1 4932 Saccharomyces cerevisiae 469008 Escherichia coli BL21(DE3) BL21(DE3) PLASMID pET-3a database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-06-24 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y RCSB 2003-03-22 REL The submitted conformer models are the 20 structures with the lowest restraint energies, restraint violations, and RMS deviations from ideal covalent geometry 80 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 3D_13C-filtered,_13C-edited_NOESY 2D_DOUBLE_HALF-FILTERED_NOESY 20 mM sodium phosphate, pH 7.0, 0.2% NaN3 7.0 1 atm 298 K The structures are based on a total of 3328 distance restraints, including 3238 NOE-derived distance restraints [2560 unambiguous and 678 ambiguous restraints], 90 hydrogen bonding distance restraints, and 150 torsion angle restraints. torsion angle dynamics and simulated annealing 1 closest to the average 1 mM U-15N,13C Cue2 + 1 mM Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3 90% H2O/10% D2O 1 mM U-15N,13C Cue2 + 1 mM Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3 99.996% D2O 1 mM Cue2 + 1 mM U-15N,13C Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3 90% H2O/10% D2O 1 mM Cue2 + 1 mM U-15N,13C Ubiquitin; 20 mM sodium phosphate buffer, pH 7.0, 0.2% NaN3 99.996% D2O Varian collection VNMR 6.1b Accelrys processing Felix 98.0 and 2000 Accelrys data analysis Felix 98.0 and 2000 Brunger et al. structure solution CNS 1.1 Linge and Nilges structure solution ARIA 1.2 Linge and Nilges refinement ARIA 1.2 Brunger et al. refinement CNS 1.1 600 Varian INOVA ASN 6 n 1 ASN 6 A ASP 7 n 2 ASP 7 A ASP 8 n 3 ASP 8 A HIS 9 n 4 HIS 9 A GLU 10 n 5 GLU 10 A SER 11 n 6 SER 11 A LYS 12 n 7 LYS 12 A LEU 13 n 8 LEU 13 A SER 14 n 9 SER 14 A ILE 15 n 10 ILE 15 A LEU 16 n 11 LEU 16 A MET 17 n 12 MET 17 A ASP 18 n 13 ASP 18 A MET 19 n 14 MET 19 A PHE 20 n 15 PHE 20 A PRO 21 n 16 PRO 21 A ALA 22 n 17 ALA 22 A ILE 23 n 18 ILE 23 A SER 24 n 19 SER 24 A LYS 25 n 20 LYS 25 A SER 26 n 21 SER 26 A LYS 27 n 22 LYS 27 A LEU 28 n 23 LEU 28 A GLN 29 n 24 GLN 29 A VAL 30 n 25 VAL 30 A HIS 31 n 26 HIS 31 A LEU 32 n 27 LEU 32 A LEU 33 n 28 LEU 33 A GLU 34 n 29 GLU 34 A ASN 35 n 30 ASN 35 A ASN 36 n 31 ASN 36 A ASN 37 n 32 ASN 37 A ASP 38 n 33 ASP 38 A LEU 39 n 34 LEU 39 A ASP 40 n 35 ASP 40 A LEU 41 n 36 LEU 41 A THR 42 n 37 THR 42 A ILE 43 n 38 ILE 43 A GLY 44 n 39 GLY 44 A LEU 45 n 40 LEU 45 A LEU 46 n 41 LEU 46 A LEU 47 n 42 LEU 47 A LYS 48 n 43 LYS 48 A GLU 49 n 44 GLU 49 A ASN 50 n 45 ASN 50 A ASP 51 n 46 ASP 51 A ASP 52 n 47 ASP 52 A LYS 53 n 48 LYS 53 A SER 54 n 49 SER 54 A MET 1 n 1 MET 1 B GLN 2 n 2 GLN 2 B ILE 3 n 3 ILE 3 B PHE 4 n 4 PHE 4 B VAL 5 n 5 VAL 5 B LYS 6 n 6 LYS 6 B THR 7 n 7 THR 7 B LEU 8 n 8 LEU 8 B THR 9 n 9 THR 9 B GLY 10 n 10 GLY 10 B LYS 11 n 11 LYS 11 B THR 12 n 12 THR 12 B ILE 13 n 13 ILE 13 B THR 14 n 14 THR 14 B LEU 15 n 15 LEU 15 B GLU 16 n 16 GLU 16 B VAL 17 n 17 VAL 17 B GLU 18 n 18 GLU 18 B SER 19 n 19 SER 19 B SER 20 n 20 SER 20 B ASP 21 n 21 ASP 21 B THR 22 n 22 THR 22 B ILE 23 n 23 ILE 23 B ASP 24 n 24 ASP 24 B ASN 25 n 25 ASN 25 B VAL 26 n 26 VAL 26 B LYS 27 n 27 LYS 27 B SER 28 n 28 SER 28 B LYS 29 n 29 LYS 29 B ILE 30 n 30 ILE 30 B GLN 31 n 31 GLN 31 B ASP 32 n 32 ASP 32 B LYS 33 n 33 LYS 33 B GLU 34 n 34 GLU 34 B GLY 35 n 35 GLY 35 B ILE 36 n 36 ILE 36 B PRO 37 n 37 PRO 37 B PRO 38 n 38 PRO 38 B ASP 39 n 39 ASP 39 B GLN 40 n 40 GLN 40 B GLN 41 n 41 GLN 41 B ARG 42 n 42 ARG 42 B LEU 43 n 43 LEU 43 B ILE 44 n 44 ILE 44 B PHE 45 n 45 PHE 45 B ALA 46 n 46 ALA 46 B GLY 47 n 47 GLY 47 B LYS 48 n 48 LYS 48 B GLN 49 n 49 GLN 49 B LEU 50 n 50 LEU 50 B GLU 51 n 51 GLU 51 B ASP 52 n 52 ASP 52 B GLY 53 n 53 GLY 53 B ARG 54 n 54 ARG 54 B THR 55 n 55 THR 55 B LEU 56 n 56 LEU 56 B SER 57 n 57 SER 57 B ASP 58 n 58 ASP 58 B TYR 59 n 59 TYR 59 B ASN 60 n 60 ASN 60 B ILE 61 n 61 ILE 61 B GLN 62 n 62 GLN 62 B LYS 63 n 63 LYS 63 B GLU 64 n 64 GLU 64 B SER 65 n 65 SER 65 B THR 66 n 66 THR 66 B LEU 67 n 67 LEU 67 B HIS 68 n 68 HIS 68 B LEU 69 n 69 LEU 69 B VAL 70 n 70 VAL 70 B LEU 71 n 71 LEU 71 B ARG 72 n 72 ARG 72 B LEU 73 n 73 LEU 73 B ARG 74 n 74 ARG 74 B GLY 75 n 75 GLY 75 B GLY 76 n 76 GLY 76 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 B O LEU 15 B O LEU 15 B N ILE 3 B N ILE 3 B N PHE 4 B N PHE 4 B O LEU 67 B O LEU 67 B O HIS 68 B O HIS 68 B N ILE 44 B N ILE 44 B N PHE 45 B N PHE 45 B O LYS 48 B O LYS 48 1 A ASP 7 -151.63 -39.04 1 A ASP 8 -150.67 39.48 1 A ALA 22 -163.53 -41.22 1 A ASN 35 -77.74 33.65 1 A ASN 50 -79.87 45.78 1 A ASP 52 -176.67 134.98 1 B ASP 21 -83.06 -126.88 1 B LYS 48 -173.19 138.94 1 B GLN 62 -76.75 -154.64 1 B ARG 74 59.27 -141.22 2 A ASP 8 -174.81 54.60 2 A ALA 22 -168.37 -44.38 2 A ASN 36 64.57 -72.96 2 A ASN 37 -162.09 -30.33 2 A ASP 38 -39.27 123.04 2 A LYS 48 -80.83 43.00 2 A ASN 50 -81.05 39.74 2 A ASP 52 63.97 129.89 2 B ASP 21 -84.29 -123.38 2 B THR 22 -171.72 141.35 2 B TYR 59 -85.74 31.91 2 B LYS 63 -179.93 140.74 2 B ARG 74 64.31 133.34 3 A ASP 7 75.78 -47.19 3 A ALA 22 -165.74 -39.76 3 A ASN 35 -81.23 38.69 3 A LYS 48 -78.93 39.77 3 A ASN 50 -90.07 41.60 3 A ASP 51 -176.15 133.95 3 A ASP 52 -171.09 132.94 3 B LYS 11 -164.68 116.12 3 B SER 20 -92.39 36.60 3 B ASP 21 -80.52 -134.04 3 B THR 22 -175.94 143.70 3 B GLU 34 -140.40 -32.19 3 B ALA 46 69.43 -34.25 3 B LEU 50 -82.87 35.96 3 B GLU 51 51.16 -167.26 3 B ARG 74 -173.63 46.87 4 A ASP 7 69.30 138.12 4 A ASP 8 -76.06 40.03 4 A ALA 22 -166.93 -42.93 4 A ASN 35 -77.64 37.48 4 A ASN 50 -69.62 -133.15 4 A ASP 51 71.79 -24.32 4 A LYS 53 -169.57 -43.31 4 B LEU 8 -42.60 102.13 4 B LYS 11 -172.88 139.28 4 B SER 19 -77.35 43.54 4 B SER 20 -168.58 49.68 4 B LEU 43 -69.55 86.60 4 B LYS 48 -173.27 144.18 5 A ASP 7 -170.16 -30.77 5 A ASP 8 -166.50 43.11 5 A ASN 36 65.41 -71.00 5 A ASN 37 -177.09 32.96 5 A LYS 48 -81.47 40.78 5 B SER 19 -76.62 30.05 5 B ASP 21 -61.20 -113.98 5 B THR 22 -170.12 146.32 5 B LYS 48 -173.02 138.69 5 B ARG 54 -67.21 -140.91 5 B SER 65 -72.72 -151.29 6 A ASP 7 -176.35 -44.23 6 A ASP 8 -142.24 45.17 6 A PRO 21 -80.36 49.87 6 A ALA 22 -168.36 -44.15 6 A ASN 35 -78.78 44.21 6 A GLU 49 -75.34 31.77 6 A ASN 50 -145.76 46.72 6 A ASP 51 -169.93 -45.23 6 A ASP 52 58.00 -133.03 6 B THR 7 -77.02 -148.36 6 B LEU 8 -108.38 48.50 6 B THR 9 -160.60 -52.27 6 B ASP 21 -84.43 -124.61 6 B LYS 48 -172.36 143.29 6 B ARG 54 -64.67 -145.08 6 B GLN 62 -85.35 -157.80 7 A ASP 7 -172.15 -40.05 7 A ASP 8 -176.20 40.89 7 A ASN 35 -83.94 36.53 7 A ASN 36 64.22 -74.68 7 A ASN 37 179.32 28.97 7 A ASP 52 -175.22 128.00 7 A LYS 53 -177.97 -46.53 7 B THR 7 -70.23 -150.66 7 B LEU 8 -105.78 41.86 7 B THR 9 -150.15 -53.37 7 B ASP 21 -77.13 -126.01 7 B THR 22 -174.73 140.48 7 B GLN 62 -80.95 -141.79 8 A ASP 8 -172.54 45.12 8 A ALA 22 -77.08 32.97 8 A ASN 35 -79.66 35.64 8 A LYS 48 -87.20 34.55 8 A ASN 50 -80.77 48.84 8 B THR 9 -158.01 -55.37 8 B LYS 11 -161.57 115.43 8 B VAL 17 -177.23 131.17 8 B SER 20 -80.26 35.61 8 B ASP 21 -99.65 -122.15 8 B THR 22 -172.55 140.74 8 B ASP 39 -83.29 40.24 8 B GLN 40 -162.19 35.23 8 B GLN 41 -171.37 146.35 8 B ALA 46 69.81 -64.48 8 B TYR 59 -82.46 30.96 8 B LYS 63 179.20 148.64 9 A ASP 7 75.57 -42.32 9 A ASN 35 -61.92 -71.03 9 A ASN 36 167.76 42.27 9 B LEU 8 -48.04 87.59 9 B SER 19 -77.68 42.30 9 B SER 20 -166.71 38.80 9 B ASP 21 -108.03 -120.78 9 B ALA 46 70.89 -30.64 9 B LEU 50 -75.45 44.14 9 B GLU 51 51.67 -166.59 9 B ASP 52 -145.40 52.12 9 B ARG 54 -141.11 -144.00 9 B GLN 62 -66.86 -114.90 9 B ARG 74 57.29 -86.06 10 A ASP 7 -167.86 -143.93 10 A ALA 22 -161.75 -46.83 10 A ASN 35 -79.36 28.83 10 A ASN 36 63.12 -72.62 10 A ASN 37 178.09 72.65 10 A LYS 48 -82.92 43.17 10 A ASN 50 -157.32 48.37 10 B LYS 11 177.67 117.26 10 B SER 19 -76.09 27.56 10 B SER 20 -165.10 28.06 10 B ASP 21 -76.09 -121.71 10 B THR 22 -173.77 138.71 10 B ARG 72 -72.23 -116.26 10 B ARG 74 -67.98 -141.64 11 A ASP 8 -166.89 33.88 11 A ALA 22 -166.92 -44.96 11 A ASN 35 -85.12 32.24 11 A ASN 36 64.90 -71.89 11 A ASN 37 -179.09 33.45 11 A LYS 48 -81.36 41.22 11 A ASN 50 -164.22 -50.40 11 A ASP 51 54.69 -132.65 11 A ASP 52 66.47 136.57 11 B SER 20 -97.84 35.57 11 B ASP 21 -83.45 -126.22 11 B THR 22 -172.94 143.51 11 B LYS 48 -173.11 146.11 11 B ARG 74 -149.02 -45.06 12 A ASP 7 -173.91 -147.95 12 A ASP 8 -83.20 33.61 12 A PRO 21 -80.31 49.98 12 A ALA 22 -168.19 -42.88 12 A ASN 35 -82.70 35.93 12 A ASN 36 63.29 -72.78 12 A ASN 37 -178.95 34.40 12 A ASN 50 -84.02 36.72 12 A ASP 51 -78.86 -146.95 12 A LYS 53 -175.97 133.36 12 B ASP 21 -59.89 -121.43 12 B LYS 48 -172.74 137.35 12 B ARG 54 -66.23 -143.21 13 A ASP 7 -157.20 -47.27 13 A ASP 8 -174.22 103.99 13 A ALA 22 -165.71 -48.14 13 A ASN 35 -83.71 32.38 13 A ASN 36 64.75 -72.82 13 A ASN 37 -177.92 31.21 13 A LYS 48 -82.98 42.36 13 A ASN 50 -70.46 -144.50 13 A ASP 51 55.37 -122.19 13 A ASP 52 63.27 120.46 13 B SER 20 -82.18 49.86 13 B LYS 33 -68.84 -72.45 13 B ALA 46 70.52 -32.97 13 B GLN 62 -84.02 -155.47 13 B SER 65 -73.75 -152.83 13 B ARG 72 -63.02 -72.94 13 B ARG 74 57.85 -112.40 14 A ASP 7 65.21 139.53 14 A ASP 8 -167.96 41.06 14 A ALA 22 -166.98 -42.97 14 A ASN 35 -77.29 34.55 14 A LYS 48 -77.18 30.13 14 A ASN 50 -79.81 46.43 14 A ASP 52 -77.62 43.35 14 B LYS 11 -162.13 118.54 14 B ASP 21 -79.33 -128.82 14 B THR 22 -175.03 140.46 14 B LYS 33 -73.68 -76.66 14 B ASP 39 -78.92 33.89 14 B GLN 40 -161.29 31.60 14 B LYS 48 -172.71 142.48 14 B GLN 62 -74.97 -138.50 14 B ARG 72 -68.12 -105.48 14 B ARG 74 -68.34 -135.10 15 A ASP 7 -69.11 -123.87 15 A ALA 22 -165.81 -39.39 15 A ASN 35 -64.73 -76.10 15 A ASN 36 171.08 36.04 15 A ASP 51 -177.19 128.60 15 A ASP 52 -83.22 41.74 15 A LYS 53 57.17 -120.66 15 B SER 20 -90.73 33.07 15 B ASP 21 -83.67 -141.22 15 B GLN 40 -79.09 35.44 15 B ALA 46 68.11 -31.54 15 B ASP 52 -76.37 46.35 15 B SER 65 -80.30 -148.27 15 B ARG 72 57.19 166.69 15 B LEU 73 -74.83 -147.91 16 A PHE 20 -113.85 76.97 16 A ALA 22 -165.20 -43.07 16 A ASN 35 -76.87 40.03 16 A LYS 48 -81.35 41.71 16 A ASP 51 65.94 132.51 16 B SER 19 -77.29 42.20 16 B SER 20 -160.44 40.45 16 B ASP 21 -121.56 -121.56 16 B LYS 33 -73.09 -76.83 16 B GLN 40 -89.52 38.15 16 B ALA 46 68.98 -65.27 16 B ASP 52 -77.88 46.54 17 A ASP 8 -155.32 34.87 17 A ASN 36 172.47 -63.29 17 A ASN 37 173.43 33.01 17 A LYS 48 -82.08 39.54 17 A ASP 51 -163.07 -44.21 17 B SER 19 -77.15 41.52 17 B SER 20 -163.53 32.99 17 B ASP 21 -98.20 -122.35 17 B LYS 48 -173.14 144.56 17 B GLN 62 -85.10 -155.00 17 B SER 65 -69.38 -151.51 17 B ARG 72 -75.12 -134.24 17 B ARG 74 -168.15 47.22 18 A ASP 8 -81.94 41.47 18 A ASN 35 -81.10 36.71 18 A ASN 36 64.48 -73.15 18 A ASN 37 177.37 36.05 18 A LYS 48 -83.86 43.42 18 A ASP 52 -177.04 -53.75 18 A LYS 53 -74.99 -147.00 18 B THR 12 -107.18 76.29 18 B SER 20 -93.76 33.28 18 B ASP 21 -90.83 -123.74 18 B LYS 33 -70.72 -72.10 18 B GLN 40 -78.55 34.33 18 B ALA 46 68.66 -65.81 19 A PRO 21 -78.36 44.58 19 A ALA 22 -170.60 41.79 19 A ASN 35 -64.86 -78.26 19 A ASN 36 166.96 38.00 19 A LYS 48 -88.11 42.21 19 A ASP 52 -175.75 137.26 19 B ASP 21 -91.36 -134.73 19 B GLN 62 -79.54 -157.31 19 B ARG 74 -79.50 45.45 20 A ASP 7 -145.54 -33.53 20 A ASP 8 -75.63 39.35 20 A ALA 22 -168.45 -45.24 20 A ASN 35 -79.27 38.77 20 A LYS 48 -83.24 43.14 20 A ASN 50 -170.69 55.80 20 A ASP 51 -64.77 -137.80 20 B SER 20 -90.31 35.10 20 B ASP 21 -78.22 -130.78 20 B THR 22 -176.93 139.41 20 B LYS 48 -172.55 145.56 20 B ARG 74 51.87 -133.78 Solution Structure of a CUE-Ubiquitin Complex 1 N N 2 N N A HIS 9 A HIS 4 HELX_P A MET 19 A MET 14 1 1 11 A LYS 25 A LYS 20 HELX_P A GLU 34 A GLU 29 1 2 10 A LEU 39 A LEU 34 HELX_P A LEU 47 A LEU 42 1 3 9 B ILE 23 B ILE 23 HELX_P B GLU 34 B GLU 34 1 4 12 B LEU 56 B LEU 56 HELX_P B TYR 59 B TYR 59 1 5 4 CELL CYCLE PROTEIN-PROTEIN COMPLEX, CELL CYCLE CUE2_YEAST UNP 1 6 P36075 NDDHESKLSILMDMFPAISKSKLQVHLLENNNDLDLTIGLLLKENDDKS UBIQ_YEAST UNP 2 1 P61864 MQIFVKTLTGKTITLEVESSDTIDNVKSKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 6 54 1OTR 6 54 P36075 A 1 1 49 1 76 1OTR 1 76 P61864 B 2 1 76 5 anti-parallel parallel anti-parallel anti-parallel B THR 12 B THR 12 B GLU 16 B GLU 16 B GLN 2 B GLN 2 B THR 7 B THR 7 B THR 66 B THR 66 B LEU 71 B LEU 71 B GLN 41 B GLN 41 B PHE 45 B PHE 45 B LYS 48 B LYS 48 B GLN 49 B GLN 49